A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

Clinical trial NCT07571174 · RECRUITING

Trial details

NCT number: NCT07571174
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2026-05-14
Primary completion: 2029-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.